What is CVE-2025-52653?

CVE-2025-52653 is a high-severity vulnerability in Hcl Myxalytics, classified under Cross-site Scripting. CVSS score: 7.6/10. Published 2025-10-03.

How severe is CVE-2025-52653?

High severity. CVSS v3 base score is 7.6 out of 10.

Is CVE-2025-52653 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

XSS in Hcl Myxalytics

CVE-2025-52653

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.002 (15.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.6 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H.

Affected products

Hcl Myxalytics — versions 6.6
Hcltech Dryice_myxalytics — versions 6.6

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

Public proof-of-concept exploits

fkie-cad/nvd-json-data-feeds

References

psirt@hcl.com (Vendor Advisory)

Frequently asked questions

What is CVE-2025-52653?: CVE-2025-52653 is a high-severity vulnerability in Hcl Myxalytics, classified under Cross-site Scripting. CVSS score: 7.6/10. Published 2025-10-03.
How severe is CVE-2025-52653?: High severity. CVSS v3 base score is 7.6 out of 10.
Is CVE-2025-52653 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.